NDC 70860-784
Valproate Sodium
Valproate Sodium
Valproate Sodium is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Athenex Pharmaceutical Division, Llc.. The primary component is Valproate Sodium.
| Product ID | 70860-784_37440743-cd78-454a-8d6e-305376ec8bd4 |
| NDC | 70860-784 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Valproate Sodium |
| Generic Name | Valproate Sodium |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2022-11-01 |
| Marketing Category | ANDA / |
| Application Number | ANDA076295 |
| Labeler Name | Athenex Pharmaceutical Division, LLC. |
| Substance Name | VALPROATE SODIUM |
| Active Ingredient Strength | 100 mg/mL |
| Pharm Classes | Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |